Sarcopenia
This project aims to develop a long-acting peptide suitable for once-weekly dosing for treatment of age related loss of muscle mass and function. The project is partnered with Vasa Therapeutics. www.vasatherapeutics.com
Chronic Neuropathic & Postoperative Pain Management
Two parallel programs focus on developing a peripherally-restricted, long-acting peptide therapeutic as a non-addictive alternatives to opioid treatment for chronic neuropathic and postoperative pain.
Achondroplasia Treatment
Our goal is to develop a best-in-class, once-weekly treatment for children to accelerate bone growth and improve symptoms of achondroplasia.
Short Bowel Syndrome (SBS)
Our SBS program focuses on developing a best-in-class, once-weekly treatment to reduce the need for intravenous nutrition and fluids in patients with SBS.